Kimberly Palatini Jackson

Kimberly Palatini Jackson, Ph.D., is an accomplished research professional with extensive experience in biochemical screening and pharmacological assay development. Currently serving as Study Director at Metabolon, Inc. since October 2019, Kimberly previously held prominent roles such as Gene Therapy Senior Scientist at Eurofins Lancaster Laboratories and Senior Research Scientist at CurlBio LLC, where leadership in NAFLD treatment research was demonstrated. With a Ph.D. in Nutrition Sciences from North Carolina State University, Kimberly's research expertise encompasses high-throughput assays, CRISPR-Cas technology, and phenotypic screening of bioactive compounds. Notable accomplishments include managing an international collaboration leading to multiple publications, training emerging scientists, and receiving recognition as an invited speaker and finalist at prestigious scientific meetings.